| Diabetic neuropathy is a common complication of type 2 diabetes that can cause pain, numbness, and tingling in the extremities, particularly the feet and legs. Left untreated, diabetic neuropathy can lead to serious complications such as foot ulcers and amputations. However, with proper management, the symptoms of diabetic neuropathy can be improved, and the risk of complications can be reduced. In this blog post, we will discuss the best practices for managing diabetic neuropathy in patients with type 2 diabetes. |
|
|
Patients with type 2 diabetes are generally not considered to be at high risk for developing DKA. However, there are certain situations where DKA may occur, including during periods of illness, infection, or stress, or in patients with poor glycemic control. |
| |
| |
| Incretin therapies are a class of drugs used in the management of type 2 diabetes. They work by mimicking the effects of incretin hormones, which are naturally occurring hormones in the body that stimulate insulin secretion and reduce glucagon secretion in response to food intake. This leads to better glycemic control and a lower risk of diabetes-related complications. |
| |
|
|
|